Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Melanin-concentrating hormone receptor 1 | ||
Ligand | BDBM50186849 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_376573 (CHEMBL866622) | ||
Ki | 10±n/a nM | ||
Citation | Wu, WL; Burnett, DA; Caplen, MA; Domalski, MS; Bennett, C; Greenlee, WJ; Hawes, BE; O'Neill, K; Weig, B; Weston, D; Spar, B; Kowalski, T Design and synthesis of orally efficacious benzimidazoles as melanin-concentrating hormone receptor 1 antagonists. Bioorg Med Chem Lett16:3674-8 (2006) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Melanin-concentrating hormone receptor 1 | |||
Name: | Melanin-concentrating hormone receptor 1 | ||
Synonyms: | G-protein coupled receptor 24 | GPR24 | MCH receptor 1 | MCH-1R | MCH-R1 | MCHR | MCHR-1 | MCHR1 | MCHR1_HUMAN | Melanin Concentrating Hormone 1 | Melanin-Concentrating Hormone Receptor 1 (MCH1R) | Melanin-concentrating hormone receptor | Melanin-concentrating hormone receptor 1 (MCH-1) | Melanin-concentrating hormone receptor 1 (MCH1) | Melanin-concentrating hormone receptor 1 (MCHR-1) | Melanin-concentrating hormone receptor 1 (MCHR1) | SLC-1 | SLC1 | Somatostatin receptor-like protein | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 45976.27 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Membranes from CHO-K1 cells stably expressing human MCH1R were used in assays. | ||
Residue: | 422 | ||
Sequence: |
| ||
BDBM50186849 | |||
n/a | |||
Name | BDBM50186849 | ||
Synonyms: | 5-{4-[(1-cyclopropylmethyl-piperidin-4-ylidene)-(5-fluoro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-methyl]-phenyl}-nicotinonitrile | CHEMBL377372 | ||
Type | Small organic molecule | ||
Emp. Form. | C30H25F4N5 | ||
Mol. Mass. | 531.5466 | ||
SMILES | Fc1cc2[nH]c(nc2cc1C(F)(F)F)C(=C1CCN(CC2CC2)CC1)c1ccc(cc1)-c1cncc(c1)C#N |(27.19,2.64,;26.42,1.3,;24.89,1.3,;24.13,-.03,;22.62,-.35,;22.46,-1.88,;23.87,-2.51,;24.89,-1.36,;26.42,-1.36,;27.19,-.03,;28.73,-.03,;30.27,-.03,;28.73,-1.57,;28.73,1.51,;21.13,-2.65,;21.13,-4.19,;19.79,-4.95,;19.79,-6.49,;21.12,-7.26,;21.12,-8.8,;19.78,-9.57,;18.25,-9.57,;19.02,-10.91,;22.46,-6.49,;22.46,-4.95,;19.79,-1.88,;18.46,-2.66,;17.12,-1.89,;17.13,-.34,;18.46,.43,;19.79,-.34,;15.79,.43,;14.47,-.34,;13.14,.42,;13.13,1.97,;14.47,2.74,;15.8,1.97,;14.47,4.29,;14.47,5.83,)| | ||
Structure |